(Reuters) - Drug distributor Cardinal Health Inc said on Friday it would sell its Cordis medical device business to private equity firm Hellman & Friedman in a deal valued at about $1 billion.
Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila
Our Standards: The Thomson Reuters Trust Principles.
风险提示：本文所述仅代表作者个人观点，不代表 Followme 的官方立场。Followme 不对内容的准确性、完整性或可靠性作出任何保证，对于基于该内容所采取的任何行为，不承担任何责任，除非另有书面明确说明。
喜欢的话，赞赏支持一下
加载失败()